UK markets closed

BioNTech SE (22UA.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
82.50+2.35 (+2.93%)
At close: 06:23PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 19.59B
Enterprise value 3.26B
Trailing P/E 21.54
Forward P/E 7.24
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.24
Price/book (mrq)0.98
Enterprise value/revenue 0.85
Enterprise value/EBITDA 3.00

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3-22.52%
S&P500 52-week change 322.36%
52-week high 3116.00
52-week low 377.50
50-day moving average 384.13
200-day moving average 393.31

Share statistics

Avg vol (3-month) 31.32k
Avg vol (10-day) 3995
Shares outstanding 5240.99M
Implied shares outstanding 6243.68M
Float 888.96M
% held by insiders 162.84%
% held by institutions 118.34%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 402 Jun 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 24.36%
Operating margin (ttm)40.00%

Management effectiveness

Return on assets (ttm)2.62%
Return on equity (ttm)4.62%

Income statement

Revenue (ttm)3.82B
Revenue per share (ttm)15.87
Quarterly revenue growth (yoy)-65.40%
Gross profit (ttm)N/A
EBITDA 1.11B
Net income avi to common (ttm)930.3M
Diluted EPS (ttm)3.83
Quarterly earnings growth (yoy)-79.90%

Balance sheet

Total cash (mrq)16.55B
Total cash per share (mrq)69.61
Total debt (mrq)219.1M
Total debt/equity (mrq)1.08%
Current ratio (mrq)9.43
Book value per share (mrq)85.17

Cash flow statement

Operating cash flow (ttm)5.37B
Levered free cash flow (ttm)4.14B